From Medscape Rheumatology

European League Against Rheumatism (EULAR) Congress 2018

June 13 - 16, 2018; Amsterdam, the Netherlands

June 13 - 16, 2018 Amsterdam, the Netherlands

EULAR 2018 NSAIDs Increase Cardiovascular Risk in Osteoarthritis Nonsteroidal anti-inflammatory drugs contribute to the elevated risk for cardiovascular disease in people with osteoarthritis, new research shows, but alternatives for pain management are limited.
Medscape Medical News, June 15, 2018

Nonmedical Biosimilar Switch Results Surprise Investigators When the Danish government mandated a switch to the infliximab biosimilar, researchers had the perfect opportunity to study the effect on patients with rheumatologic inflammatory disease.
Medscape Medical News, Jun 30, 2017
Tocilizumab Triumphs in Methotrexate Combo for RA It is not always clear which biologic to add to methotrexate for rheumatoid arthritis, but a new comparison between tocilizumab and a number of TNF inhibitors has some suggestions.
Medscape Medical News, Jun 20, 2017
Biologics Comparison in Rheumatoid Arthritis Surprises A Swedish study had rheumatologists debating the top contenders for second-line therapy in patients with rheumatoid arthritis who do not respond to TNF inhibitor therapy.
Medscape Medical News, Jun 20, 2017

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

Jonathan Kay, MD
UMass Memorial Medical Center, Worcester, Massachusetts Bio
Presentation: Impact of immunogenicity on clinical efficacy and administration related reaction in TNF inhibitors: A pooled-analysis from three biosimilar studies in patients with rheumatoid arthritis
Date: June 14, 2018
Muhammed Khan, MD
Case Western Reserve University, Cleveland, Ohio
Presentation: Occurrence of ankylosing spondylitis among relatives of probands with radiographic and non-radiographic disease and axial spondyloarthritis
Date: June 14, 2018
Presentation: Effect of diacerin vs glucosamine-chondroitin on disease progression, and measures of function in persons with knee osteoarthritis: A 2-year randomized, double-blink, placebo controlled trial
Date: June 16, 2018
Sergio Schwartzman, MD
New York-Presbyterian Hospital
Presentation: Integrated safety data analysis across phase 3 clinical studies for intravenous golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Date: June 15, 2018
Presentation: Efficacy of tofacitinib patients with moderate to severe rheumatoid arthritis by baseline C-reactive protein levels and erythrocyte sedimentation rates
Presentation: Efficacy of baricitinib in patients with rheumatoid arthritis who failed 2 or more DMARDs
Date: June 16, 2018

Previous Coverage

Related Resources